The DOI matches its Crossref record; 156 of the 156 references it cites were found in a registry or an index.
Therapeutic options for 5-lipoxygenase inhibitors
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Catalano, A., Caprari, P., Soddu, S., Procopio, A. D., & Romano, M. (2004) · The FASEB Journal · doi:10.1096/fj.04-2258fje · Cited by 40
RetractedProstaglandins and Leukotrienes: Advances in Eicosanoid Biology
Funk, C. D. (2001) · Science · doi:10.1126/science.294.5548.1871 · Cited by 3,817
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological Effects
Samuelsson, B., Dahlén, S.-E., Lindgren, J. Å., Rouzer, C. A., & Serhan, C. N. (1987) · Science · doi:10.1126/science.2820055 · Cited by 2,233
Lewis (1990) · doi:10.1056/nejm199009063231006 · Cited by 1,200
Dahlén, S. E., Björk, J., Hedqvist, P., Arfors, K. E., Hammarström, S., Lindgren, J. A., & Samuelsson, B. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3887 · Cited by 1,019
Leukotriene C: a slow-reacting substance from murine mastocytoma cells.
Murphy, R. C., Hammarström, S., & Samuelsson, B. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4275 · Cited by 991
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke
Helgadottir, A., Manolescu, A., Thorleifsson, G., Gretarsdottir, S., Jonsdottir, H., Thorsteinsdottir, U., Samani, N. J., Gudmundsson, G., Grant, S. F. A., Thorgeirsson, G., et al. (2004) · Nature Genetics · doi:10.1038/ng1311 · Cited by 927
Requirement of a 5-lipoxygenase-activating protein for leukotriene synthesis
Dixon, R. A. F., Diehl, R. E., Opas, E., Rands, E., Vickers, P. J., Evans, J. F., Gillard, J. W., & Miller, D. K. (1990) · Nature · doi:10.1038/343282a0 · Cited by 774
Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease
Sharon, P., & Stenson, W. F. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80015-3 · Cited by 738
Role of cytosolic phospholipase A2 in allergic response and parturition
Uozumi, N., Kume, K., Nagase, T., Nakatani, N., Ishii, S., Tashiro, F., Komagata, Y., Maki, K., Ikuta, K., Ouchi, Y., et al. (1997) · Nature · doi:10.1038/37622 · Cited by 704
Inflammation: Basic Principles and Clinical Correlates
Ehrlich, G. E. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.1.123 · Cited by 622
Arachidonate 5-Lipoxygenase Promoter Genotype, Dietary Arachidonic Acid, and Atherosclerosis
Dwyer, J. H., Allayee, H., Dwyer, K. M., Fan, J., Wu, H., Mar, R., Lusis, A. J., & Mehrabian, M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa025079 · Cited by 619
Drazen, J. M., Yandava, C. N., Dubé, L., Szczerback, N., Hippensteel, R., Pillari, A., Israel, E., Schork, N., Silverman, E. S., Katz, D. A., et al. (1999) · Nature Genetics · doi:10.1038/9680 · Cited by 560
Inhibition of arachidonate 5-lipoxygenase triggers massive apoptosis in human prostate cancer cells
Ghosh, J., & Myers, C. E. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13182 · Cited by 496
Identification and isolation of a membrane protein necessary for leukotriene production
Miller, D. K., Gillard, J. W., Vickers, P. J., Sadowski, S., Léveillé, C., Mancini, J. A., Charleson, P., Dixon, R. A. F., Ford-Hutchinson, A. W., Fortin, R., et al. (1990) · Nature · doi:10.1038/343278a0 · Cited by 459
Spanbroek, R., Gräbner, R., Lötzer, K., Hildner, M., Urbach, A., Rühling, K., Moos, M. P. W., Kaiser, B., Cohnert, T. U., Wahlers, T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242716099 · Cited by 458
Channon, J. Y., & Leslie, C. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39374-3 · Cited by 441
Mehrabian, M., Allayee, H., Wong, J., Shih, W., Wang, X.-P., Shaposhnik, Z., Funk, C. D., & Lusis, A. J. (2002) · Circulation Research · doi:10.1161/01.res.0000028008.99774.7f · Cited by 422
5-lipoxygenase inhibitory activity of zileuton.
Carter, G. W., Young, P. R., Albert, D. H., Bouska, J., Dyer, R., Bell, R. L., Summers, J. B., & Brooks, D. W. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23086-5 · Cited by 420
Dahlén, S. E., Hansson, G., Hedqvist, P., Björck, T., Granström, E., & Dahlén, B. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.6.1712 · Cited by 415
Liberation of histamine and formation of lysocithin‐like substances by cobra venom
Feldberg, W., & Kellaway, C. H. (1938) · The Journal of Physiology · doi:10.1113/jphysiol.1938.sp003674 · Cited by 377
Helgadottir, A., Manolescu, A., Helgason, A., Thorleifsson, G., Thorsteinsdottir, U., Gudbjartsson, D. F., Gretarsdottir, S., Magnusson, K. P., Gudmundsson, G., Hicks, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1692 · Cited by 370
Ford-Hutchinson, A. W., Gresser, M., & Young, R. N. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.002123 · Cited by 364
The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm
Zhao, L., Moos, M. P. W., Gräbner, R., Pédrono, F., Fan, J., Kaiser, B., John, N., Schmidt, S., Spanbroek, R., Lötzer, K., et al. (2004) · Nature Medicine · doi:10.1038/nm1099 · Cited by 354
Kanaoka, Y., & Boyce, J. A. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1503 · Cited by 351
Montelukast Added to Inhaled Beclomethasone in Treatment of Asthma
LAVIOLETTE, M., MALMSTROM, K., LU, S., CHERVINSKY, P., PUJET, J.-C., PESZEK, I., ZHANG, J., & REISS, T. F. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.6.9803042 · Cited by 350
Klickstein, L. B., Shapleigh, C., & Goetzl, E. J. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109947 · Cited by 345
In, K. H., Asano, K., Beier, D., Grobholz, J., Finn, P. W., Silverman, E. K., Silverman, E. S., Collins, T., Fischer, A. R., Keith, T. P., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119241 · Cited by 334
Rouzer, C. A., & Kargman, S. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)38066-9 · Cited by 319
Rouzer, C. A., Ford-Hutchinson, A. W., Morton, H. E., & Gillard, J. W. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40034-3 · Cited by 314
Lam, B. K., Penrose, J. F., Freeman, G. J., & Austen, K. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7663 · Cited by 296
International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors
Brink, C., Dahlén, S.-E., Drazen, J., Evans, J. F., Hay, D. W. P., Nicosia, S., Serhan, C. N., Shimizu, T., & Yokomizo, T. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.8 · Cited by 286
Funk, C. D. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(96)00107-5 · Cited by 265
Arachidonic Acid Stimulates Prostate Cancer Cell Growth: Critical Role of 5-Lipoxygenase
Ghosh, J., & Myers, C. E. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6799 · Cited by 259
Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling.
Avis, I. M., Jett, M., Boyle, T., Vos, M. D., Moody, T., Treston, A. M., Martínez, A., & Mulshine, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118480 · Cited by 249
Leukotriene B4 Receptor Antagonism Reduces Monocytic Foam Cells in Mice
Aiello, R. J., Bourassa, P.-A., Lindsey, S., Weng, W., Freeman, A., & Showell, H. J. (2002) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq0302.105593 · Cited by 247
Hakonarson, H., Thorvaldsson, S., Helgadottir, A., Gudbjartsson, D., Zink, F., Andresdottir, M., Manolescu, A., Arnar, D. O., Andersen, K., Sigurdsson, A., et al. (2005) · JAMA · doi:10.1001/jama.293.18.2245 · Cited by 236
Helgadottir, A., Gretarsdottir, S., St. Clair, D., Manolescu, A., Cheung, J., Thorleifsson, G., Pasdar, A., Grant, S. F. A., Whalley, L. J., Hakonarson, H., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/428066 · Cited by 232
Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase
Albert, D., Zündorf, I., Dingermann, T., Müller, W. E., Steinhilber, D., & Werz, O. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)01387-4 · Cited by 230
Self-citation5‐lipoxygenase‐activating protein is an arachidonate binding protein
Mancini, J. A., Abramovitz, M., Cox, M. E., Wong, E., Charleson, S., Perrier, H., Wang, Z., Prasit, P., & Vickers, P. J. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80528-3 · Cited by 224
Mehrabian, M., Allayee, H., Stockton, J., Lum, P. Y., Drake, T. A., Castellani, L. W., Suh, M., Armour, C., Edwards, S., Lamb, J., et al. (2005) · Nature Genetics · doi:10.1038/ng1619 · Cited by 221
Collagen-induced Arthritis Is Reduced in 5-Lipoxygenase-activating Protein-deficient Mice
Griffiths, R. J., Smith, M., Roach, M. L., Stock, J. L., Stam, E. J., Milici, A. J., Scampoli, D. N., Eskra, J. D., Byrum, R. S., Koller, B. H., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.6.1123 · Cited by 219
5-Lipoxygenase is phosphorylated by p38 kinase-dependent MAPKAP kinases
Werz, O., Klemm, J., Samuelsson, B., & Rådmark, O. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050588997 · Cited by 216
Self-citationGoldman, D. W., & Goetzl, E. J. (1984) · The Journal of experimental medicine · doi:10.1084/jem.159.4.1027 · Cited by 215
5‐Lipoxygenase‐activating protein stimulates the utilization of arachidonic acid by 5‐lipoxygenase
ABRAMOVITZ, M., WONG, E., COX, M. E., RICHARDSON, C. D., LI, C., & VICKERS, P. J. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18012.x · Cited by 211
Role of Leukotriene B4Receptors in the Development of Atherosclerosis: Potential Mechanisms
Subbarao, K., Jala, V. R., Mathis, S., Suttles, J., Zacharias, W., Ahamed, J., Ali, H., Tseng, M. T., & Haribabu, B. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000110503.16605.15 · Cited by 208
Inhibitors of lipoxygenase: a new class of cancer chemopreventive agents
Rioux, N. (1998) · Carcinogenesis · doi:10.1093/carcin/19.8.1393 · Cited by 204
Avis, I., Hong, S. H., Martínez, A., Moody, T., Choi, Y. H., Trepel, J., Das, R., Jett, M., & Mulshine, J. L. (2001) · The FASEB Journal · doi:10.1096/fj.00-0866fje · Cited by 202
Tager, A. M., Dufour, J. H., Goodarzi, K., Bercury, S. D., von Andrian, U. H., & Luster, A. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.439 · Cited by 195
Selenoenzymes regulate the activity of leukocyte 5-lipoxygenase via the peroxide tone.
Weitzel, F., & Wendel, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53251-8 · Cited by 194
Qiao, L., Kozoni, V., Tsioulias, G. J., Koutsos, M. I., Hanif, R., Shiff, S. J., & Rigas, B. (1995) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00100-q · Cited by 193
Clària, J., Lee, M. H., & Serhan, C. N. (1996) · Molecular Medicine · doi:10.1007/bf03401642 · Cited by 192
Öhd, J. F., Nielsen, C. K., Campbell, J., Landberg, G., Löfberg, H., & Sjölander, A. (2003) · Gastroenterology · doi:10.1053/gast.2003.50011 · Cited by 191
Leukotriene A4 Hydrolase/Aminopeptidase, the Gatekeeper of Chemotactic Leukotriene B4 Biosynthesis
Haeggström, J. Z. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400027200 · Cited by 188
5-Lipoxygenase: Cellular Biology and Molecular Pharmacology
Werz, O. (2002) · Current Drug Target -Inflammation & Allergy · doi:10.2174/1568010023344959 · Cited by 188
Self-citationHennig, R., Ding, X.-Z., Tong, W.-G., Schneider, M. B., Standop, J., Friess, H., Büchler, M. W., Pour, P. M., & Adrian, T. E. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64198-3 · Cited by 184
ALOX5AP Gene and the PDE4D Gene in a Central European Population of Stroke Patients
Lõhmussaar, E., Gschwendtner, A., Mueller, J. C., Org, T., Wichmann, E., Hamann, G., Meitinger, T., & Dichgans, M. (2005) · Stroke · doi:10.1161/01.str.0000157587.59821.87 · Cited by 184
Mellor, E. A., Maekawa, A., Austen, K. F., & Boyce, J. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141221498 · Cited by 180
Werz, O., Bürkert, E., Samuelsson, B., Rådmark, O., & Steinhilber, D. (2002) · Blood · doi:10.1182/blood.v99.3.1044 · Cited by 177
Self-citationLeukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis.
Davidson, E. M., Rae, S. A., & Smith, M. J. (1983) · Annals of the Rheumatic Diseases · doi:10.1136/ard.42.6.677 · Cited by 177
Haribabu, B., Verghese, M. W., Steeber, D. A., Sellars, D. D., Bock, C. B., & Snyderman, R. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.433 · Cited by 175
JAKOBSSON, P.-J., MORGENSTERN, R., MANCINI, J., FORD-HUTCHINSON, A., & PERSSON, B. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_1.ltta-5 · Cited by 165
Molecular Basis of the Specific Subcellular Localization of the C2-like Domain of 5-Lipoxygenase
Kulkarni, S., Das, S., Funk, C. D., Murray, D., & Cho, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112393200 · Cited by 162
Identification of a Novel Human Eicosanoid Receptor Coupled to Gi/o
Hosoi, T., Koguchi, Y., Sugikawa, E., Chikada, A., Ogawa, K., Tsuda, N., Suto, N., Tsunoda, S., Taniguchi, T., & Ohnuki, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203194200 · Cited by 162
Fierro, I. M., Kutok, J. L., & Serhan, C. N. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.2.385 · Cited by 158
Molecular mechanisms involved in the regulation of prostaglandin biosynthesis by glucocorticoids
Goppelt‐Struebe, M. (1997) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00018-x · Cited by 155
Role of the 5-Lipoxygenase–activating Protein (FLAP) in Murine Acute Inflammatory Responses
Byrum, R. S., Goulet, J. L., Griffiths, R., & Koller, B. H. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.6.1065 · Cited by 155
Lipoxygenase Inhibitors Abolish Proliferation of Human Pancreatic Cancer Cells
Ding, X., Iversen, P. L., Cluck, M. W., Knezetic, J. A., & Adrian, T. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1012 · Cited by 155
The N-terminal “β-Barrel” Domain of 5-Lipoxygenase Is Essential for Nuclear Membrane Translocation
Chen, X., & Funk, C. D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008203200 · Cited by 154
Whitney, L. W., Ludwin, S. K., McFarland, H. F., & Biddison, W. E. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00438-6 · Cited by 152
Designing therapeutically effective 5-lipoxygenase inhibitors
McMillan, R. M., & Walker, E. R. H. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90100-k · Cited by 147
Hong, S. H., Avis, I. M., Vos, M. D., Martı́nez, A., Treston, A. M., & Mulshine, J. L. (1999) · PubMed · Cited by 146
Fischer, L., Szellas, D., Rådmark, O., Steinhilber, D., & Werz, O. (2003) · The FASEB Journal · doi:10.1096/fj.02-0815fje · Cited by 146
Self-citation5-Lipoxygenase: A Target for Antiinflammatory Drugs Revisited
Steinhilber, D. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220207211259 · Cited by 146
Self-citationWerz, O., Bürkert, E., Fischer, L., Szellas, D., Dishart, D., Samuelsson, B. O., Rådmark, O., & Steinhilber, D. (2002) · The FASEB Journal · doi:10.1096/fj.01-0909fje · Cited by 145
Self-citationChemotactic activity in inflammatory bowel disease: Role of leukotriene B4
Lobos, E. A., Sharon, P., & Stenson, W. F. (1987) · Digestive Diseases and Sciences · doi:10.1007/bf01296664 · Cited by 143
The discovery and development of zileuton: An orally active 5-lipoxygenase inhibitor
Bell, R. L., Young, P. R., Albert, D. H., Lanni, C., Summers, J. B., Brooks, D. W., Rubin, P. D., & Carter, G. W. (1992) · International Journal of Immunopharmacology · doi:10.1016/0192-0561(92)90182-k · Cited by 138
Biochemistry, biology and chemistry of the 5-lipoxygenase product 5-oxo-ETE
Powell, W. S., & Rokach, J. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.04.002 · Cited by 138
5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice
Irvin, C. G., Tu, Y., Sheller, J. R., et al. (1997) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.1997.272.6.l1053 · Cited by 138
Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B 4 synthetic capacity
Luo, M., Jones, S. M., Peters-Golden, M. L., & Brock, T. G. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2133253100 · Cited by 136
Protein Kinase A Inhibits Leukotriene Synthesis by Phosphorylation of 5-Lipoxygenase on Serine 523
Luo, M., Jones, S. M., Phare, S. M., Coffey, M., Peters-Golden, M. L., & Brock, T. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312568200 · Cited by 132
Werz, O., Szellas, D., Steinhilber, D., & Rådmark, O. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111945200 · Cited by 130
Self-citationThe effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells
Bortuzzo, C., Hanif, R., Kashfi, K., Staiano‐Coico, L., Shiff, S. J., & Rigas, B. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00003-3 · Cited by 130
Hoque, A. M., Lippman, S. M., Wu, T.-T., Xu, Y. L., Zheng, L., Swisher, S. G., Zhang, H., Cao, L., Ajani, J. A., & Xu, X.-C. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi026 · Cited by 129
Flamand, N., Surette, M. E., Picard, S., Bourgoin, S. G., & Borgeat, P. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.2.250 · Cited by 128
Romano, M., Catalano, A., Nutini, M., D’Urbano, E., CRESCENZI, C., Clària, J., LIBNER, R., Davì, G., & Procopio, A. D. (2001) · The FASEB Journal · doi:10.1096/fj.01-0150com · Cited by 127
Li, N., Sood, S., Wang, S., Fang, M., Wang, P., Sun, Z., Yang, C. S., & Chen, X. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1684 · Cited by 124
5-Lipoxygenase regulates senescence-like growth arrest by promoting ROS-dependent p53 activation
Catalano, A., Rodilossi, S., Caprari, P., Coppola, V., & Procopio, A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600502 · Cited by 123
LTB4 stimulates growth of human pancreatic cancer cells via MAPK and PI-3 kinase pathways
Tong, W., Ding, X., Talamonti, M., Bell, R. H., & Adrian, T. E. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.166 · Cited by 122
Leukotriene B4 stimulates osteoclastic bone resorption both in vitro and in vivo
Garcia, C., Boyce, B. F., Gilles, J. A., Dallas, M., Qiao, M., Mundy, G. R., & Bonewald, L. F. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650111105 · Cited by 121
Asthma and leukotrienes: antileukotrienes as novel anti‐asthmatic drugs
Claesson, H., & Se, D. (1999) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1999.00418.x · Cited by 118
A New Concept for Acne Therapy: A Pilot Study With Zileuton, an Oral 5-Lipoxygenase Inhibitor
Zouboulis, C. C., Nestoris, S., Adler, Y. D., Orth, M., Orfanos, C. E., Picardo, M., Camera, E., & Cunliffe, W. J. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.5.668 · Cited by 116
Riddick, C. A., Ring, W. L., Baker, J. R., Hodulik, C. R., & Bigby, T. D. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00112.x · Cited by 114
Hawkey, C., Dubé, L. M., Rountree, L., Linnen, P., & Lancaster, J. F. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041232 · Cited by 114
Tong, W., Ding, X., Hennig, R., Witt, R. C., Standop, J., Pour, P. M., & Adrian, T. E. (2002) · PubMed · Cited by 114
Brideau, C., Chan, C. S., Charleson, S. E., Denis, D., Evans, J. F., Ford‐Hutchinson, A. W., Fortin, R., Gillard, J. W., Guay, J., Guévremont, D., et al. (1992) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y92-107 · Cited by 113
Differential Leukotriene Constrictor Responses in Human Atherosclerotic Coronary Arteries
Allen, S. P., Dashwood, M. R., Morrison, K. J. M., & Yacoub, M. H. (1998) · Circulation · doi:10.1161/01.cir.97.24.2406 · Cited by 112
Nielsen, C. K., Campbell-Tofte, J., Öhd, J., Mörgelin, M., Riesbeck, K., Landberg, G., & Sjölander, A. (2005) · Cancer Research · doi:10.1158/0008-5472.732.65.3 · Cited by 111
Ghosh, J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.01.100 · Cited by 108
Jones, C. E., Holden, S., Tenaillon, L., Bhatia, U., Seuwen, K., TRANTER, P. R., Turner, J., Kettle, R., Bouhelal, R., Charlton, S. J., et al. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.3.471 · Cited by 108
Cyclooxygenase and 5‐lipoxygenase pathways in the vessel wall: Role in atherosclerosis
Vila, L. (2004) · Medicinal Research Reviews · doi:10.1002/med.10065 · Cited by 107
McGill, K. A., & Busse, W. W. (1996) · The Lancet · doi:10.1016/s0140-6736(95)12297-4 · Cited by 107
Rådmark, O. (2002) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(02)00032-1 · Cited by 106
Lötzer, K., Spanbroek, R., Hildner, M., Urbach, A., Heller, R., Bretschneider, E., Galczenski, H., Evans, J. F., & Habenicht, A. J. R. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000082690.23131.cb · Cited by 106
Leukotrienes and the cardiovascular system
Feuerstein, G. (1984) · Prostaglandins · doi:10.1016/0090-6980(84)90015-7 · Cited by 103
Werz, O., & Steinhilber, D. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0090r.x · Cited by 100
Self-citation5-Lipoxygenase Metabolites Inhibit Bone Formation in Vitro
Traianedes, K., Dallas, M. R., Garrett, I. R., et al. (1998) · Endocrinology · doi:10.1210/endo.139.7.6115 · Cited by 96
Zhi, H., Zhang, J., Hu, G., Lu, J., Wang, X., Zhou, C., Wu, M., & Liu, Z. (2003) · International Journal of Cancer · doi:10.1002/ijc.11225 · Cited by 95
Phosphorylation by Protein Kinase A Inhibits Nuclear Import of 5-Lipoxygenase
Luo, M., Jones, S. M., Flamand, N., Aronoff, D. M., Peters-Golden, M. L., & Brock, T. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507045200 · Cited by 93
The 5-Lipoxygenase Promoter Is Regulated by DNA Methylation
Uhl, J. H., Klan, N., Rose, M., Entian, K., Werz, O., & Steinhilber, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107665200 · Cited by 92
Self-citationZileuton, a 5-lipoxygenase inhibitor in rheumatoid arthritis.
Weinblatt, M. E., Jm, K., Js, C., Helfgott, S. M., Al, M., Petrillo, G. F., Henson, B. A. B., Rubin, P. D., & Sperling, R. I. (1992) · PubMed · Cited by 92
Roberts, W., Simon, T., Berlin, R., Haggitt, R., Snyder, E., Stenson, W. F., Hanauer, S., Reagan, J., Cagliola, A., Tanaka, W., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9041233 · Cited by 90
Chen, X., Li, N., Wang, S., Wu, N., Hong, J., Jiao, X., Krasna, M. J., Beer, D. G., & Yang, C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.14.1053 · Cited by 84
5-Lipoxygenase, a Marker for Early Pancreatic Intraepithelial Neoplastic Lesions
Hennig, R., Grippo, P. J., Ding, X.-Z., Rao, S. M., Büchler, M. W., Friess, H., Talamonti, M., Bell, R. H., & Adrian, T. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4090 · Cited by 82
Cloning of cDNA Encoding a Putative Chemoattractant Receptor
Owman, C., Nilsson, C. F., & Lolait, S. J. (1996) · Genomics · doi:10.1006/geno.1996.0541 · Cited by 79
Boado, R. J., Pardridge, W. M., Vinters, H. V., & Black, K. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9044 · Cited by 78
The relation between obesity and asthmatic airway inflammation
Leung, T. F., Li, C., Lam, C. W. K., Au, C. S. S., Yung, E. C.-M., Chan, I. H.-S., Wong, G., & Fok, T. F. (2004) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2004.00164.x · Cited by 78
Sjöström, M., Johansson, A., Schröder, O., Qiu, H., Palmblad, J. E. W., & Haeggström, J. Z. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000082689.46538.df · Cited by 77
5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease
Rask-Madsen, J., Bukhave, K., Laursen, L., & Lauritsen, K. (1992) · Inflammation Research · doi:10.1007/bf01996094 · Cited by 74
Paredes, Y., Massicotte, F., Pelletier, J., Martel‐Pelletier, J., Laufer, S., & Lajeunesse, D. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10357 · Cited by 73
Expression of 5-lipoxygenase in differentiating human skin keratinocytes.
Janssen-Timmen, U., Vickers, P. J., Wittig, U., Lehmann, W., Stark, H.-J., Fusenig, N. E., Rosenbach, T. O., Rådmark, O., Samuelsson, B. O., & Habenicht, A. J. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.15.6966 · Cited by 70
ALOX5AP expression, but not gene haplotypes, is associated with obesity and insulin resistance
Kaaman, M., Rydén, M., Axelsson, T., Nordström, E. A., Sicard, A., Bouloumié, A., Langin, D., Arner, P., & Dahlman, I. A. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803147 · Cited by 70
Jiang, W. G., Douglas-Jones, A. G., & Mansel, R. E. (2005) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.10.005 · Cited by 68
Hill, E. M., Maclouf, J., Murphy, R. C., & Henson, P. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41633-x · Cited by 67
5-oxo-ETE induces pulmonary eosinophilia in an integrin-dependent manner in Brown Norway rats.
Stamatiou, P. B., Hamid, Q. A., Taha, R. A., Yu, W., Issekutz, T. B., Rokach, J., KHANAPURE, S. P., & Powell, W. S. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1995 · Cited by 67
Leukotrienes C4 and D4 psoriatic skin lesions
Brain, S. D., Camp, R. D. R., Black, A. K., Dowd, P. M., Greaves, M. W., Ford‐Hutchinson, A. W., & Charleson, S. E. (1985) · Prostaglandins · doi:10.1016/0090-6980(85)90084-x · Cited by 66
5-Lipoxygenase expression in Langerhans cells of normal human epidermis
Spanbroek, R., Stark, H., Janssen-Timmen, U., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.663 · Cited by 64
5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.
Rask-Madsen, J., Bukhave, K., Laursen, L., & Lauritsen, K. (1992) · PubMed · Cited by 62
Leukotriene B4 Receptor and the Function of Its Helix 8
Okuno, T., Yokomizo, T., Hori, T., Miyano, M., & Shimizu, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.r500007200 · Cited by 62
5-Oxo-6,8,11,14-eicosatetraenoic acid induces the infiltration of granulocytes into human skin
Muro, S., Hamid, Q. A., Olivenstein, R., Taha, R. A., Rokach, J., & Powell, W. S. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)01888-8 · Cited by 60
Studies on the Regulation and Localization of 5‐Lipoxygenase in Human B‐Lymphocytes
Jakobsson, P., Shaskin, P., Larsson, P., Feltenmark, S., Odlander, B., Aguilar‐Santelises, M., Jondal, M., Biberfeld, P., & Claesson, H. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20778.x · Cited by 59
KOVALENKO, G. (1996) · Experiment · doi:10.1163/2211730x96x00180 · Cited by 57
5-lipoxygenase: enzyme expression and regulation of activity
Steinhilber, D. (1994) · Pharmaceutica Acta Helvetiae · doi:10.1016/0031-6865(94)90024-8 · Cited by 55
Self-citationGhosh, J. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01201-4 · Cited by 54
Expression of 5-oxoETE receptor in prostate cancer cells: Critical role in survival
Sundaram, S., & Ghosh, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.189 · Cited by 54
International Union of Pharmacology XLIV. Nomenclature for the Oxoeicosanoid Receptor
Brink, C., Dahlén, S., Drazen, J. M., Evans, J. F., Hay, D. W. P., Rovati, G. E., Serhan, C. N., Shimizu, T., & Yokomizo, T. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.1.4 · Cited by 53
Iversen, L., Fogh, K., Ziboh, V. A., Kristensen, P. K., Schmedes, A., & Kragballe, K. (1993) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12469865 · Cited by 50
Ding, X., Tong, W., & Adrian, T. E. (2003) · Oncology · doi:10.1159/000074640 · Cited by 47
Haynes, J., Baliga, B. S., Obiako, B. O., Ofori-Acquah, S. F., & Pace, B. S. (2004) · Blood · doi:10.1182/blood-2003-08-2969 · Cited by 47
Leukotrienes in the cerebrospinal fluid of multiple sclerosis patients
Neu, I. S., Mallinger, J., Wildfeuer, A., & Mehlber, L. (1992) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb05491.x · Cited by 45
Brooks, C. D. W., Stewart, A. O., Basha, A., Bhatia, P., Ratajczyk, J. D., Martin, J. G., Craig, R. A., Kolasa, T., Bouska, J. B., Lanni, C., et al. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00024a004 · Cited by 45
STRAIF, D., Werz, O., Kellner, R., Bahr, U., & Steinhilber, D. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490455 · Cited by 44
Self-citationHörnig, C., Albert, D., Fischer, L., Hörnig, M., Rådmark, O., Steinhilber, D., & Werz, O. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500068200 · Cited by 42
Self-citationPicard, S., Plante, H., Mancini, J. A., & Borgeat, P. (2005) · Biochemical Journal · doi:10.1042/bj20050669 · Cited by 41
5-Lipoxygenase inhibitors with histamine H 1 receptor antagonist activity
Lewis, T. A., Bayless, L., Eckman, J. B., Ellis, J. L., Grewal, G. S., Libertine, L., Nicolas, J. M., Scannell, R. T., Wels, B. F., Wenberg, K., et al. (2004) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.02.005 · Cited by 39
Wedi, B., & Kapp, A. (2001) · BioDrugs · doi:10.2165/00063030-200115110-00004 · Cited by 38
Flynn, M. A., Qiao, M., Garcia, C., Dallas, M., & Bonewald, L. F. (1999) · Calcified Tissue International · doi:10.1007/s002239900595 · Cited by 32
Mancini, J. A., Waterman, H., & Riendeau, D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32842 · Cited by 31
Effects of synthetic peptido-leukotrienes on bone resorption in vitro
Garcia, C., Qiao, M., Chen, D., Kirchen, M. E., Gallwitz, W., Mundy, G. R., & Bonewald, L. F. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110413 · Cited by 29
Franchi-Miller, C., & Jl, S. (1995) · Bone · doi:10.1016/s8756-3282(95)00173-5 · Cited by 28
LTB4 Can Directly Stimulate Human Osteoclast Formation from PBMC Independent of RANKL
Jiang, J., Lv, H., Lin, J., Jiang, D., & Chen, Z. (2005) · Artificial Cells Blood Substitutes and Biotechnology · doi:10.1080/10731190500289784 · Cited by 25
Anderson, G. I., MacQuarrie, R., Osinga, C., Chen, Y. F., Langman, M., & Gilbert, R. W. (2001) · Journal of Biomedical Materials Research · doi:10.1002/jbm.1035 · Cited by 24
5-Lipoxygenase Activation in Psoriasis: A Dead Issue?
Ford‐Hutchinson, A. W. (2009) · Skin Pharmacology · doi:10.1159/000211152 · Cited by 24
Influence of 5-Lipoxygenase on in vitro Growth of Human Mammary Carcinoma Cell Line MCF-7
Przylipiak, A., Hafner, J., Przylipiak, J., Köhn, F.-M., Runnebaum, B., & Rabe, T. (1998) · Gynecologic and Obstetric Investigation · doi:10.1159/000010000 · Cited by 17
Cited by
Resolvins and protectins in inflammation resolution
Serhan, C. N., & Petasis, N. A. (2011) · Chemical Reviews · doi:10.1021/cr100396c · Cited by 996
5-Lipoxygenase: regulation of expression and enzyme activity
Rådmark, O., Werz, O., Steinhilber, D., & Samuelsson, B. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.06.002 · Cited by 471
Self-citationAnti-Inflammatory Drugs as Anticancer Agents
Zappavigna, S., Cossu, A. M., Grimaldi, A., Bocchetti, M., Ferraro, G. A., Nicoletti, G. F., Filosa, R., & Caraglia, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072605 · Cited by 395
Biosynthesis and metabolism of leukotrienes
Murphy, R. C., & Gijón, M. A. (2007) · Biochemical Journal · doi:10.1042/bj20070289 · Cited by 319
Boswellia serrata: An Overall Assessment of In Vitro, Preclinical, Pharmacokinetic and Clinical Data
Abdel-Tawab, M., Werz, O., & Schubert-Zsilavecz, M. (2011) · Clinical Pharmacokinetics · doi:10.2165/11586800-000000000-00000 · Cited by 311
Self-citation
Metadata
- Authors
- Werz, O., & Steinhilber, D.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2006-12
- Volume
- 112
- Issue
- 3
- Pages
- 701-718
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2025563699
- Cited by
- 260
- References
- 156
- FWCI
- 6.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.